Associate Director, WW Medical Cardiovascular & Immunology, Professional Societies

Princeton, New Jersey, United States

Auto‑apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Affairs, Pharmaceutical, Professional SocietiesIndustries

Requirements

Candidates should possess a Bachelor's degree in a relevant field, along with a minimum of 8 years of experience in medical affairs, professional societies, or a related area. Strong communication and interpersonal skills are essential, as is the ability to work effectively with cross-functional teams. Experience with budget management and financial tracking is also required.

Responsibilities

The Associate Director will partner with Professional Society Leads to facilitate society interactions, prepare materials, track engagement activities, and ensure timely execution of plans. They will maintain regular communication with professional societies, contribute to the development and management of society engagement budgets, represent BMS at society meetings, support cross-functional collaboration, ensure compliance with company policies and regulatory requirements, and prepare internal reports and meeting summaries.

Skills

Communication

Interpersonal Skills

Budget Management

Financial Tracking

Cross-functional Collaboration

Regulatory Compliance

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free